Advancing ASO Therapies for Ophthalmic Disorders: Addressing Challenges & Expanding Applications in Ophthalmology
Time: 9:00 am
day: Day One 11th
Details:
- Overview of antisense oligonucleotides (ASOs) and their role in treating ophthalmic disorders
- Exploring the potential of ASOs in broader applications beyond splicing modulation
- Overview of recent advancements in ASO design and delivery methods
- Highlighting efforts in developing functional assays and organoid models for assessing ASO efficacy